11月6日,减肥和糖尿病制药商诺和诺德公布的2024年第三季度营业利润符合预期,公司缩小了全年销售额和利润指引范围。1)主要财务数据:营收:第三季度净销售额为713.11亿丹麦克朗,同比增长22%。前三季度营收2047亿丹麦克朗,同比增长23%。净利润:第三季度净利润为273.01亿丹麦克朗,同比增长21%,高于市场预期的267亿丹麦克朗。前三季度净利润727.58亿丹麦克朗,同比增长18%。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.